Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 121.320
Filtrer
1.
Int J Mol Sci ; 25(13)2024 Jul 08.
Article de Anglais | MEDLINE | ID: mdl-39000589

RÉSUMÉ

Mitogen-activated protein kinase kinase 1 (MAPK kinase 1, MEK1) is a key kinase in the mitogen-activated protein kinase (MAPK) signaling pathway. MEK1 mutations have been reported to lead to abnormal activation that is closely related to the malignant growth and spread of various tumors, making it an important target for cancer treatment. Targeting MEK1, four small-molecular drugs have been approved by the FDA, including Trametinib, Cobimetinib, Binimetinib, and Selumetinib. Recently, a study showed that modification with dehydroalanine (Dha) can also lead to abnormal activation of MEK1, which has the potential to promote tumor development. In this study, we used molecular dynamics simulations and metadynamics to explore the mechanism of abnormal activation of MEK1 caused by the Dha modification and predicted the inhibitory effects of four FDA-approved MEK1 inhibitors on the Dha-modified MEK1. The results showed that the mechanism of abnormal activation of MEK1 caused by the Dha modification is due to the movement of the active segment, which opens the active pocket and exposes the catalytic site, leading to sustained abnormal activation of MEK1. Among four FDA-approved inhibitors, only Selumetinib clearly blocks the active site by changing the secondary structure of the active segment from α-helix to disordered loop. Our study will help to explain the mechanism of abnormal activation of MEK1 caused by the Dha modification and provide clues for the development of corresponding inhibitors.


Sujet(s)
Alanine , MAP Kinase Kinase 1 , Simulation de dynamique moléculaire , MAP Kinase Kinase 1/métabolisme , MAP Kinase Kinase 1/composition chimique , Alanine/analogues et dérivés , Alanine/composition chimique , Alanine/pharmacologie , Alanine/métabolisme , Humains , Domaine catalytique , Inhibiteurs de protéines kinases/pharmacologie , Inhibiteurs de protéines kinases/composition chimique , Activation enzymatique/effets des médicaments et des substances chimiques , Benzimidazoles/pharmacologie , Benzimidazoles/composition chimique
2.
Sci Rep ; 14(1): 16442, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-39013997

RÉSUMÉ

Wounds that occur in adults form scars due to fibrosis, whereas those in embryos regenerate. If wound healing in embryos is mimicked in adults, scarring can be reduced. We found that mouse fetuses could regenerate tissues up to embryonic day (E) 13, but visible scars remained thereafter. This regeneration pattern requires actin cable formation at the epithelial wound margin via activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK). Here, we investigated whether the AMPK-activating effect of salicylate, an anti-inflammatory drug, promotes regenerative wound healing. Salicylate administration resulted in actin cable formation and complete wound regeneration in E14 fetuses, in which scarring should have normally occurred, and promoted contraction of the panniculus carnosus muscle, resulting in complete wound regeneration. In vitro, salicylate further induced actin remodeling in mouse epidermal keratinocytes in a manner dependent on cell and substrate target-specific AMPK activation and subsequent regulation of Rac1 signaling. Furthermore, salicylate promoted epithelialization, enhanced panniculus carnosus muscle contraction, and inhibited scar formation in adult mice. Administration of salicylates to wounds immediately after injury may be a novel method for preventing scarring by promoting a wound healing pattern similar to that of embryonic wounds.


Sujet(s)
AMP-Activated Protein Kinases , Actines , Cicatrisation de plaie , Animaux , AMP-Activated Protein Kinases/métabolisme , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Souris , Actines/métabolisme , Salicylates/pharmacologie , Kératinocytes/effets des médicaments et des substances chimiques , Kératinocytes/métabolisme , Protéine G rac1/métabolisme , Contraction musculaire/effets des médicaments et des substances chimiques , Transduction du signal/effets des médicaments et des substances chimiques , Cicatrice/métabolisme , Cicatrice/anatomopathologie , Activation enzymatique/effets des médicaments et des substances chimiques
3.
J Obes ; 2024: 7204607, 2024.
Article de Anglais | MEDLINE | ID: mdl-38831961

RÉSUMÉ

Obesity is a complex chronic disease characterized by excess body fat (adipose) that is harmful to health and has been a major global health problem. It may be associated with several diseases, such as nonalcoholic fatty liver disease (NAFLD). Polyunsaturated fatty acids (PUFA) are lipid mediators that have anti-inflammatory characteristics and can be found in animals and plants, with capybara oil (CO) being a promising source. So, we intend to evaluate the hepatic pathophysiological alterations in C57Bl/6 mice with NAFLD, caused by obesity, and the possible beneficial effects of OC in the treatment of this disease. Eighteen 3-month-old male C57Bl/6 mice received a control or high-fat diet for 18 weeks. From the 15th to the 18th week, the animals received treatment-through orogastric gavage-with placebo or free capybara oil (5 g/kg). Parameters inherent to body mass, glucose tolerance, evaluation of liver enzymes, percentage of hepatic steatosis, oxidative stress, the process of cell death with the apoptotic biomarkers (Bax, Bcl2, and Cytochrome C), and the ultrastructure of hepatocytes were analyzed. Even though the treatment with CO was not able to disassemble the effects on the physiological parameters, it proved to be beneficial in reversing the morphological and ultrastructural damage present in the hepatocytes. Thus, demonstrating that CO has beneficial effects in reducing steatosis and the apoptotic pathway, it is a promising treatment for NAFLD.


Sujet(s)
Apoptose , Foie , Stéatose hépatique non alcoolique , Huiles , Rodentia , Souris de lignée C57BL , Stéatose hépatique non alcoolique/étiologie , Stéatose hépatique non alcoolique/thérapie , Mâle , Animaux , Souris , Hépatocytes/effets des médicaments et des substances chimiques , Hépatocytes/anatomopathologie , Hépatocytes/ultrastructure , Huiles/pharmacologie , Huiles/usage thérapeutique , Obésité/complications , Apoptose/effets des médicaments et des substances chimiques , Foie/effets des médicaments et des substances chimiques , Foie/anatomopathologie , Foie/ultrastructure , Oxidoreductases/métabolisme , Activation enzymatique/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques
4.
Sci Adv ; 10(23): eadn7191, 2024 Jun 07.
Article de Anglais | MEDLINE | ID: mdl-38848361

RÉSUMÉ

Loss-of-function mutations in PTEN-induced kinase 1 (PINK1) are a frequent cause of early-onset Parkinson's disease (PD). Stabilization of PINK1 at the translocase of outer membrane (TOM) complex of damaged mitochondria is critical for its activation. The mechanism of how PINK1 is activated in the TOM complex is unclear. Here, we report that co-expression of human PINK1 and all seven TOM subunits in Saccharomyces cerevisiae is sufficient for PINK1 activation. We use this reconstitution system to systematically assess the role of each TOM subunit toward PINK1 activation. We unambiguously demonstrate that the TOM20 and TOM70 receptor subunits are required for optimal PINK1 activation and map their sites of interaction with PINK1 using AlphaFold structural modeling and mutagenesis. We also demonstrate an essential role of the pore-containing subunit TOM40 and its structurally associated subunits TOM7 and TOM22 for PINK1 activation. These findings will aid in the development of small-molecule activators of PINK1 as a therapeutic strategy for PD.


Sujet(s)
Protéines de transport de la membrane mitochondriale , Protéines du complexe d'import des protéines précurseurs mitochondriales , Protein kinases , Saccharomyces cerevisiae , Protein kinases/métabolisme , Protein kinases/génétique , Humains , Protéines du complexe d'import des protéines précurseurs mitochondriales/métabolisme , Protéines de transport de la membrane mitochondriale/métabolisme , Protéines de transport de la membrane mitochondriale/génétique , Saccharomyces cerevisiae/métabolisme , Saccharomyces cerevisiae/génétique , Protéines de Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/génétique , Mitochondries/métabolisme , Liaison aux protéines , Activation enzymatique , Modèles moléculaires , Sous-unités de protéines/métabolisme , Sous-unités de protéines/génétique
5.
BMC Plant Biol ; 24(1): 513, 2024 Jun 07.
Article de Anglais | MEDLINE | ID: mdl-38849759

RÉSUMÉ

BACKGROUND: The phosphorylation of the Light-Harvesting Complex of photosystem II (LHCII) driven by STATE TRANSITION 7 (STN7) kinase is a part of one of the crucial regulatory mechanisms of photosynthetic light reactions operating in fluctuating environmental conditions, light in particular. There are evidenced that STN7 can also be activated without light as well as in dark-chilling conditions. However, the biochemical mechanism standing behind this complex metabolic pathway has not been deciphered yet. RESULTS: In this work, we showed that dark-chilling induces light-independent LHCII phosphorylation in runner bean (Phaseolus coccineus L.). In dark-chilling conditions, we registered an increased reduction of the PQ pool which led to activation of STN7 kinase, subsequent LHCII phosphorylation, and possible LHCII relocation inside the thylakoid membrane. We also presented the formation of a complex composed of phosphorylated LHCII and photosystem I typically formed upon light-induced phosphorylation. Moreover, we indicated that the observed steps were preceded by the activation of the oxidative pentose phosphate pathway (OPPP) enzymes and starch accumulation. CONCLUSIONS: Our results suggest a direct connection between photosynthetic complexes reorganization and dark-chilling-induced activation of the thioredoxin system. The proposed possible pathway starts from the activation of OPPP enzymes and further NADPH-dependent thioredoxin reductase C (NTRC) activation. In the next steps, NTRC simultaneously activates ADP-glucose pyrophosphorylase and thylakoid membrane-located NAD(P)H dehydrogenase-like complex. These results in starch synthesis and electron transfer to the plastoquinone (PQ) pool, respectively. Reduced PQ pool activates STN7 kinase which phosphorylates LHCII. In this work, we present a new perspective on the mechanisms involving photosynthetic complexes while efficiently operating in the darkness. Although we describe the studied pathway in detail, taking into account also the time course of the following steps, the biological significance of this phenomenon remains puzzling.


Sujet(s)
Lumière , Phaseolus , Phaseolus/physiologie , Phaseolus/métabolisme , Phaseolus/enzymologie , Phosphorylation , Thylacoïdes/métabolisme , Complexe protéique du photosystème I/métabolisme , Basse température , Complexes collecteurs de lumière/métabolisme , Complexe protéique du photosystème II/métabolisme , Protéines végétales/métabolisme , Amidon/métabolisme , Voie des pentoses phosphates/physiologie , Activation enzymatique , Photosynthèse/physiologie , Stress physiologique , Protein-Serine-Threonine Kinases/métabolisme
7.
Cell Commun Signal ; 22(1): 306, 2024 Jun 03.
Article de Anglais | MEDLINE | ID: mdl-38831454

RÉSUMÉ

BACKGROUND: Dysregulation in histone acetylation, a significant epigenetic alteration closely associated with major pathologies including cancer, promotes tumorigenesis, inactivating tumor-suppressor genes and activating oncogenic pathways. AMP-activated protein kinase (AMPK) is a cellular energy sensor that regulates a multitude of biological processes. Although a number of studies have identified the mechanisms by which AMPK regulates cancer growth, the underlying epigenetic mechanisms remain unknown. METHODS: The impact of metformin, an AMPK activator, on cervical cancer was evaluated through assessments of cell viability, tumor xenograft model, pan-acetylation analysis, and the role of the AMPK-PCAF-H3K9ac signaling pathway. Using label-free quantitative acetylproteomics and chromatin immunoprecipitation-sequencing (ChIP) technology, the activation of AMPK-induced H3K9 acetylation was further investigated. RESULTS: In this study, we found that metformin, acting as an AMPK agonist, activates AMPK, thereby inhibiting the proliferation of cervical cancer both in vitro and in vivo. Mechanistically, AMPK activation induces H3K9 acetylation at epigenetic level, leading to chromatin remodeling in cervical cancer. This also enhances the binding of H3K9ac to the promoter regions of multiple tumor suppressor genes, thereby promoting their transcriptional activation. Furthermore, the absence of PCAF renders AMPK activation incapable of inducing H3K9 acetylation. CONCLUSIONS: In conclusion, our findings demonstrate that AMPK mediates the inhibition of cervical cancer growth through PCAF-dependent H3K9 acetylation. This discovery not only facilitates the clinical application of metformin but also underscores the essential role of PCAF in AMPK activation-induced H3K9 hyperacetylation.


Sujet(s)
AMP-Activated Protein Kinases , Prolifération cellulaire , Histone , Metformine , Tumeurs du col de l'utérus , Facteurs de transcription CBP-p300 , Tumeurs du col de l'utérus/métabolisme , Tumeurs du col de l'utérus/anatomopathologie , Tumeurs du col de l'utérus/génétique , Humains , Acétylation/effets des médicaments et des substances chimiques , Femelle , Histone/métabolisme , AMP-Activated Protein Kinases/métabolisme , Prolifération cellulaire/effets des médicaments et des substances chimiques , Animaux , Facteurs de transcription CBP-p300/métabolisme , Facteurs de transcription CBP-p300/génétique , Metformine/pharmacologie , Souris , Souris nude , Lignée cellulaire tumorale , Activation enzymatique/effets des médicaments et des substances chimiques
8.
Int J Biol Macromol ; 273(Pt 1): 133054, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38862054

RÉSUMÉ

Given the severe protein denaturation and self-aggregation during the high-temperature desolubilization, denatured soy meal (DSM) is limited by its low reactivity, high viscosity, and poor water solubility. Preparing low-cost and high-performance adhesives with DSM as the key feedstock is still challenging. Herein, this study reveals a double-enzyme co-activation method targeting DSM with the glycosidic bonds in protein-carbohydrate complexes and partial amide bonds in protein, increasing the protein dispersion index from 10.2 % to 75.1 % improves the reactivity of DSM. The green crosslinker transglutaminase (TGase) constructs a robust adhesive isopeptide bond network with high water-resistant bonding strength comparable to chemical crosslinkers. The adhesive has demonstrated high dry/wet shear strength (2.56 and 0.93 MPa) for plywood. After molecular recombination by enzyme strategy, the adhesive had the proper viscosity, high reactivity, and strong water resistance. This research showcases a novel perspective on developing a DSM-based adhesive and blazes new avenues for changes in protein structural function and adhesive performance.


Sujet(s)
Adhésifs , Glycine max , Transglutaminases , Transglutaminases/composition chimique , Transglutaminases/métabolisme , Adhésifs/composition chimique , Glycine max/composition chimique , Glycine max/enzymologie , Activation enzymatique , Viscosité , Dénaturation des protéines , Biomasse , Protéines de soja/composition chimique
9.
Eur J Pharmacol ; 977: 176711, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38839029

RÉSUMÉ

Histone deacetylase (HDAC) inhibitors are potential candidates for treating pulmonary fibrosis. MPT0E028, a novel pan-HDAC inhibitor, has been reported to exhibit antitumor activity in several cancer cell lines. In this study, we investigated the mechanism underlying the inhibitory effects of MPT0E028 on the expression of fibrogenic proteins in human lung fibroblasts (WI-38). Our results revealed that MPT0E028 inhibited transforming growth factor-ß (TGF-ß)-, thrombin-, and endothelin 1-induced connective tissue growth factor (CTGF) expression in a concentration-dependent manner. In addition, MPT0E028 suppressed TGF-ß-stimulated expression of fibronectin, collagen I, and α-smooth muscle actin (α-SMA). Furthermore, MPT0E028 inhibited the TGF-ß-induced phosphorylation of c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK). MPT0E028 reduced the increase in SMAD3 and c-Jun phosphorylation, and SMAD3-and activator protein-1 (AP-1)-luciferase activities under TGF-ß stimulation. Transfection with mitogen-activated protein kinase phosphatase-1 (MKP-1) siRNA reversed the suppressive effects of MPT0E028 on TGF-ß-induced increases in CTGF expression; JNK, p38, and ERK phosphorylation; and SMAD3 and AP-1 activation. Moreover, MPT0E028 increased MKP-1 acetylation and activity in WI-38 cells. Pretreatment with MPT0E028 reduced the fibrosis score and fibronectin, collagen, and α-SMA expression in bleomycin-induced pulmonary fibrosis mice. In conclusion, MPT0E028 induced MKP-1 acetylation and activation, which in turn inhibited TGF-ß-stimulated JNK, p38, and ERK phosphorylation; SMAD3 and AP-1 activation; and subsequent CTGF expression in human lung fibroblasts. Thus, MPT0E028 may be a potential drug for treating pulmonary fibrosis.


Sujet(s)
Facteur de croissance du tissu conjonctif , Dual Specificity Phosphatase 1 , Fibroblastes , Inhibiteurs de désacétylase d'histone , Poumon , Fibrose pulmonaire , Facteur de croissance transformant bêta , Facteur de croissance du tissu conjonctif/métabolisme , Humains , Fibroblastes/effets des médicaments et des substances chimiques , Fibroblastes/métabolisme , Fibroblastes/anatomopathologie , Fibrose pulmonaire/induit chimiquement , Fibrose pulmonaire/métabolisme , Fibrose pulmonaire/anatomopathologie , Fibrose pulmonaire/traitement médicamenteux , Animaux , Inhibiteurs de désacétylase d'histone/pharmacologie , Souris , Poumon/effets des médicaments et des substances chimiques , Poumon/anatomopathologie , Poumon/cytologie , Poumon/métabolisme , Facteur de croissance transformant bêta/métabolisme , Dual Specificity Phosphatase 1/métabolisme , Dual Specificity Phosphatase 1/génétique , Lignée cellulaire , Protéine Smad-3/métabolisme , Phosphorylation/effets des médicaments et des substances chimiques , Mâle , Activation enzymatique/effets des médicaments et des substances chimiques , Souris de lignée C57BL
10.
Life Sci ; 351: 122807, 2024 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-38852800

RÉSUMÉ

AIMS: Differentiation-inducing factor-1 (DIF-1) is a polyketide produced by Dictyostelium discoideum that inhibits growth and migration, while promoting the differentiation of Dictyostelium stalk cells through unknown mechanisms. DIF-1 localizes in stalk mitochondria. In addition to its effect on Dictyostelium, DIF-1 also inhibits growth and migration, and induces mitochondrial fission followed by mitophagy in mammalian cells, at least in part by activating AMP-activated protein kinase (AMPK). In a previous study, we found that DIF-1 binds to mitochondrial malate dehydrogenase (MDH2) and inhibits its activity in HeLa cells. In the present study, we investigated whether MDH2 serves as a pharmacological target of DIF-1 in mammalian cells. MAIN METHODS: To examine the enzymatic activity of MDH, mitochondrial morphology, and molecular mechanisms of DIF-1 action, we conducted an MDH reverse reaction assay, immunofluorescence staining, western blotting, and RNA interference using mammalian cells such as human umbilical vein endothelial cells, human cervical cancer cells, mouse endothelial cells, and mouse breast cancer cells. KEY FINDINGS: DIF-1 inhibited mitochondrial but not cytoplasmic MDH activity. Similar to DIF-1, LW6, an authentic MDH2 inhibitor, induced phosphorylation of AMPK, resulting in the phosphorylation of acetyl-CoA carboxylase (ACC) and the dephosphorylation of p70 S6 kinase with approximately the same potency. DIF-1 and LW6 induced mitochondrial fission. Furthermore, MDH2 knockdown using siRNA reproduced the DIF-1 action on the AMPK signaling and mitochondrial morphology. Conversely, an AMPK inhibitor prevented DIF-1-induced mitochondrial fission. SIGNIFICANCE: We propose that MDH2 is a mammalian target of DIF-1 for the activation of AMPK and induction of mitochondrial fission.


Sujet(s)
AMP-Activated Protein Kinases , Malate dehydrogenase , Mitochondries , Dynamique mitochondriale , Humains , AMP-Activated Protein Kinases/métabolisme , Dynamique mitochondriale/effets des médicaments et des substances chimiques , Dynamique mitochondriale/physiologie , Malate dehydrogenase/métabolisme , Mitochondries/métabolisme , Cellules HeLa , Animaux , Hexanones/pharmacologie , Hexanones/métabolisme , Cellules endothéliales de la veine ombilicale humaine/métabolisme , Activation enzymatique , Hydrocarbures chlorés
11.
Nature ; 630(8018): 1003-1011, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38926614

RÉSUMÉ

Transposases drive chromosomal rearrangements and the dissemination of drug-resistance genes and toxins1-3. Although some transposases act alone, many rely on dedicated AAA+ ATPase subunits that regulate site selectivity and catalytic function through poorly understood mechanisms. Using IS21 as a model transposase system, we show how an ATPase regulator uses nucleotide-controlled assembly and DNA deformation to enable structure-based site selectivity, transposase recruitment, and activation and integration. Solution and cryogenic electron microscopy studies show that the IstB ATPase self-assembles into an autoinhibited pentamer of dimers that tightly curves target DNA into a half-coil. Two of these decamers dimerize, which stabilizes the target nucleic acid into a kinked S-shaped configuration that engages the IstA transposase at the interface between the two IstB oligomers to form an approximately 1 MDa transpososome complex. Specific interactions stimulate regulator ATPase activity and trigger a large conformational change on the transposase that positions the catalytic site to perform DNA strand transfer. These studies help explain how AAA+ ATPase regulators-which are used by classical transposition systems such as Tn7, Mu and CRISPR-associated elements-can remodel their substrate DNA and cognate transposases to promote function.


Sujet(s)
Domaine AAA , Adenosine triphosphatases , Transposases , Adenosine triphosphatases/composition chimique , Adenosine triphosphatases/métabolisme , Adenosine triphosphatases/ultrastructure , Domaine catalytique , Cryomicroscopie électronique , ADN/composition chimique , ADN/génétique , ADN/métabolisme , ADN/ultrastructure , Éléments transposables d'ADN/génétique , Activation enzymatique , Modèles moléculaires , Multimérisation de protéines , Transposases/métabolisme , Transposases/composition chimique
12.
Mol Cell ; 84(12): 2223-2237.e4, 2024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38870937

RÉSUMÉ

In Saccharomyces cerevisiae (S. cerevisiae), Mre11-Rad50-Xrs2 (MRX)-Sae2 nuclease activity is required for the resection of DNA breaks with secondary structures or protein blocks, while in humans, the MRE11-RAD50-NBS1 (MRN) homolog with CtIP is needed to initiate DNA end resection of all breaks. Phosphorylated Sae2/CtIP stimulates the endonuclease activity of MRX/N. Structural insights into the activation of the Mre11 nuclease are available only for organisms lacking Sae2/CtIP, so little is known about how Sae2/CtIP activates the nuclease ensemble. Here, we uncover the mechanism of Mre11 activation by Sae2 using a combination of AlphaFold2 structural modeling of biochemical and genetic assays. We show that Sae2 stabilizes the Mre11 nuclease in a conformation poised to cleave substrate DNA. Several designs of compensatory mutations establish how Sae2 activates MRX in vitro and in vivo, supporting the structural model. Finally, our study uncovers how human CtIP, despite considerable sequence divergence, employs a similar mechanism to activate MRN.


Sujet(s)
Protéines de liaison à l'ADN , Endodeoxyribonucleases , Endonucleases , Protéines de Saccharomyces cerevisiae , Saccharomyces cerevisiae , Protéines de Saccharomyces cerevisiae/métabolisme , Protéines de Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/génétique , Saccharomyces cerevisiae/enzymologie , Saccharomyces cerevisiae/métabolisme , Endonucleases/métabolisme , Endonucleases/génétique , Protéines de liaison à l'ADN/métabolisme , Protéines de liaison à l'ADN/génétique , Endodeoxyribonucleases/métabolisme , Endodeoxyribonucleases/génétique , Endodeoxyribonucleases/composition chimique , Humains , Exodeoxyribonucleases/métabolisme , Exodeoxyribonucleases/génétique , Modèles moléculaires , Phosphorylation , Enzymes de réparation de l'ADN/métabolisme , Enzymes de réparation de l'ADN/génétique , Cassures double-brin de l'ADN , Acid anhydride hydrolases/métabolisme , Acid anhydride hydrolases/génétique , Mutation , Protéine homologue de MRE11/métabolisme , Protéine homologue de MRE11/génétique , Réparation de l'ADN , Activation enzymatique
13.
Cell Calcium ; 121: 102910, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38823350

RÉSUMÉ

In cardiac myocytes, the type 2a sarco/endoplasmic reticulum Ca-ATPase (SERCA2a) plays a key role in intracellular Ca regulation. Due to its critical role in heart function, SERCA2a activity is tightly regulated by different mechanisms, including micropeptides. While phospholamban (PLB) is a well-known SERCA2a inhibitor, dwarf open reading frame (DWORF) is a recently identified SERCA2a activator. Since PLB phosphorylation is the most recognized mechanism of SERCA2a activation during adrenergic stress, we studied whether PLB phosphorylation also affects SERCA2a regulation by DWORF. By using confocal Ca imaging in a HEK293 expressing cell system, we analyzed the effect of the co-expression of PLB and DWORF using a bicistronic construct on SERCA2a-mediated Ca uptake. Under these conditions of matched expression of PLB and DWORF, we found that SERCA2a inhibition by non-phosphorylated PLB prevails over DWORF activating effect. However, when PLB is phosphorylated at PKA and CaMKII sites, not only PLB's inhibitory effect was relieved, but SERCA2a was effectively activated by DWORF. Förster resonance energy transfer (FRET) analysis between SERCA2a and DWORF showed that DWORF has a higher relative affinity for SERCA2a when PLB is phosphorylated. Thus, SERCA2a regulation by DWORF responds to the PLB phosphorylation status, suggesting that DWORF might contribute to SERCA2a activation during conditions of adrenergic stress.


Sujet(s)
Protéines de liaison au calcium , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Sarcoplasmic Reticulum Calcium-Transporting ATPases/métabolisme , Protéines de liaison au calcium/métabolisme , Humains , Phosphorylation , Cellules HEK293 , Cadres ouverts de lecture/génétique , Calcium/métabolisme , Activation enzymatique , Calcium-Calmodulin-Dependent Protein Kinase Type 2/métabolisme , Cyclic AMP-Dependent Protein Kinases/métabolisme
14.
Cells ; 13(11)2024 May 31.
Article de Anglais | MEDLINE | ID: mdl-38891087

RÉSUMÉ

Ubiquitin-specific protease 14 (USP14), one of the three major proteasome-associated deubiquitinating enzymes (DUBs), is known to be activated by the AKT-mediated phosphorylation at Ser432. Thereby, AKT can regulate global protein degradation by controlling the ubiquitin-proteasome system (UPS). However, the exact molecular mechanism of USP14 activation by AKT phosphorylation at the atomic level remains unknown. By performing the molecular dynamics (MD) simulation of the USP14 catalytic domain at three different states (inactive, active, and USP14-ubiquitin complex), we characterized the change in structural dynamics by phosphorylation. We observed that the Ser432 phosphorylation induced substantial conformational changes of USP14 in the blocking loop (BL) region to fold it from an open loop into a ß-sheet, which is critical for USP14 activation. Furthermore, phosphorylation also increased the frequency of critical hydrogen bonding and salt bridge interactions between USP14 and ubiquitin, which is essential for DUB activity. Structural dynamics insights from this study pinpoint the important local conformational landscape of USP14 by the phosphorylation event, which would be critical for understanding USP14-mediated proteasome regulation and designing future therapeutics.


Sujet(s)
Simulation de dynamique moléculaire , Protéines proto-oncogènes c-akt , Ubiquitin thiolesterase , Phosphorylation , Ubiquitin thiolesterase/métabolisme , Ubiquitin thiolesterase/composition chimique , Protéines proto-oncogènes c-akt/métabolisme , Humains , Ubiquitine/métabolisme , Activation enzymatique , Domaine catalytique , Liaison aux protéines , Conformation des protéines
15.
Dis Model Mech ; 17(6)2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38826084

RÉSUMÉ

Abnormal extracellular signal-regulated kinase 1/2 (ERK1/2, encoded by Mapk3 and Mapk1, respectively) signaling is linked to multiple neurodevelopmental diseases, especially the RASopathies, which typically exhibit ERK1/2 hyperactivation in neurons and non-neuronal cells. To better understand how excitatory neuron-autonomous ERK1/2 activity regulates forebrain development, we conditionally expressed a hyperactive MEK1 (MAP2K1) mutant, MEK1S217/221E, in cortical excitatory neurons of mice. MEK1S217/221E expression led to persistent hyperactivation of ERK1/2 in cortical axons, but not in soma/nuclei. We noted reduced axonal arborization in multiple target domains in mutant mice and reduced the levels of the activity-dependent protein ARC. These changes did not lead to deficits in voluntary locomotion or accelerating rotarod performance. However, skilled motor learning in a single-pellet retrieval task was significantly diminished in these MEK1S217/221E mutants. Restriction of MEK1S217/221E expression to layer V cortical neurons recapitulated axonal outgrowth deficits but did not affect motor learning. These results suggest that cortical excitatory neuron-autonomous hyperactivation of MEK1 is sufficient to drive deficits in axon outgrowth, which coincide with reduced ARC expression, and deficits in skilled motor learning. Our data indicate that neuron-autonomous decreases in long-range axonal outgrowth may be a key aspect of neuropathogenesis in RASopathies.


Sujet(s)
Axones , Cortex cérébral , MAP Kinase Kinase 1 , Neurones , Animaux , Axones/métabolisme , Axones/anatomopathologie , MAP Kinase Kinase 1/métabolisme , MAP Kinase Kinase 1/génétique , Cortex cérébral/anatomopathologie , Neurones/métabolisme , Neurones/anatomopathologie , Apprentissage , Acide glutamique/métabolisme , Activation enzymatique , Souris , Système de signalisation des MAP kinases , Protéines du cytosquelette/métabolisme , Protéines du cytosquelette/génétique , Mutation/génétique , Mitogen-Activated Protein Kinase 3/métabolisme , Protéines de tissu nerveux/métabolisme , Activité motrice , Mitogen-Activated Protein Kinase 1/métabolisme
16.
Braz Oral Res ; 38: e034, 2024.
Article de Anglais | MEDLINE | ID: mdl-38747821

RÉSUMÉ

The aim of this study was to investigate the effect of acid challenge on the activation of matrix metalloproteinases (MMPs) in the Dentinoenamel junction of primary and permanent teeth submitted to radiotherapy. For this purpose, a total of 178 dental fragments obtained from molars were used, and randomly divided into 2 groups (primary and permanent teeth) / 4 experimental subgroups (irradiated and non-irradiated, demineralized and non-demineralized). The fragments were exposed to radiation, with a dose fraction of 2 Gy, for 5 consecutive days, until a total dose of 60 Gy was reached, with a total of 30 cycles, for 6 weeks. To determine the activity of MMPs on the dentinoenamel junction (DEJ), in situ zymography assays on 0.6mm dental fragments were performed. To assess whether MMP activity would be impacted by an acidic environment, the fragments were placed in a demineralizing solution (pH of 4.8). The finding was that irradiation activated MMPs in DEJ and these effects were more evident in permanent when compared with primary teeth. When the effect of an acid challenge on MMPs activity was investigated, demineralization was observed not to increase MMPs activity in non-irradiated teeth, but it did increase MMPs activity in irradiated teeth. In conclusion, an acid challenge was found to exacerbate activation of MMPs in DEJ of permanent teeth submitted to irradiation, but not in primary teeth.


Sujet(s)
Matrix metalloproteinases , Matrix metalloproteinases/métabolisme , Matrix metalloproteinases/effets des radiations , Matrix metalloproteinases/analyse , Humains , Facteurs temps , Dent de lait/effets des radiations , Dent de lait/effets des médicaments et des substances chimiques , Dentine/effets des radiations , Dentine/effets des médicaments et des substances chimiques , Dentine/enzymologie , Denture permanente , Répartition aléatoire , Concentration en ions d'hydrogène , Déminéralisation dentaire , Statistique non paramétrique , Analyse de variance , Valeurs de référence , Activation enzymatique/effets des radiations , Activation enzymatique/effets des médicaments et des substances chimiques
17.
Mol Med ; 30(1): 63, 2024 May 17.
Article de Anglais | MEDLINE | ID: mdl-38760678

RÉSUMÉ

BACKGROUND: Diabetic wounds are one of the long-term complications of diabetes, with a disordered microenvironment, diabetic wounds can easily develop into chronic non-healing wounds, which can impose a significant burden on healthcare. In diabetic condition, senescent cells accumulate in the wound area and suppress the wound healing process. AMPK, as a molecule related to metabolism, has a close relationship with aging and diabetes. The purpose of this study was to investigate the effects of AMPK activation on wound healing and explore the underlying mechanisms. METHODS: AMPK activator A769662 was topically applied in wound models of diabetic mice. Alterations in the wound site were observed and analyzed by immunohistochemistry. The markers related to autophagy and ferritinophagy were analyzed by western blotting and immunofluorescence staining. The role of AMPK activation and ferritinophagy were also analyzed by western blotting. RESULTS: Our results show that AMPK activation improved diabetic wound healing and reduced the accumulation of senescent cells. Intriguingly, we found that AMPK activation-induced ferroptosis is autophagy-dependent. We detected that the level of ferritin had deceased and NCOA4 was markedly increased after AMPK activation treatment. We further investigated that NCOA4-mediated ferritinophagy was involved in ferroptosis triggered by AMPK activation. Most importantly, AMPK activation can reverse the ferroptosis-insensitive of senescent fibroblast cells in diabetic mice wound area and promote wound healing. CONCLUSIONS: These results suggest that activating AMPK can promote diabetic wound healing by reversing the ferroptosis-insensitive of senescent fibroblast cells. AMPK may serve as a regulatory factor in senescent cells in the diabetic wound area, therefore AMPK activation can become a promising therapeutic method for diabetic non-healing wounds.


Sujet(s)
AMP-Activated Protein Kinases , Autophagie , Vieillissement de la cellule , Diabète expérimental , Ferritines , Coactivateurs de récepteurs nucléaires , Cicatrisation de plaie , Animaux , Souris , Ferritines/métabolisme , AMP-Activated Protein Kinases/métabolisme , Diabète expérimental/métabolisme , Coactivateurs de récepteurs nucléaires/métabolisme , Mâle , Ferroptose , Humains , Modèles animaux de maladie humaine , Activation enzymatique
18.
Biochemistry ; 63(10): 1335-1346, 2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38690768

RÉSUMÉ

Lipoxygenases (LOXs) from pathogenic fungi are potential therapeutic targets for defense against plant and select human diseases. In contrast to the canonical LOXs in plants and animals, fungal LOXs are unique in having appended N-linked glycans. Such important post-translational modifications (PTMs) endow proteins with altered structure, stability, and/or function. In this study, we present the structural and functional outcomes of removing or altering these surface carbohydrates on the LOX from the devastating rice blast fungus, M. oryzae, MoLOX. Alteration of the PTMs did notinfluence the active site enzyme-substrate ground state structures as visualized by electron-nuclear double resonance (ENDOR) spectroscopy. However, removal of the eight N-linked glycans by asparagine-to-glutamine mutagenesis nonetheless led to a change in substrate selectivity and an elevated activation energy for the reaction with substrate linoleic acid, as determined by kinetic measurements. Comparative hydrogen-deuterium exchange mass spectrometry (HDX-MS) analysis of wild-type and Asn-to-Gln MoLOX variants revealed a regionally defined impact on the dynamics of the arched helix that covers the active site. Guided by these HDX results, a single glycan sequon knockout was generated at position 72, and its comparative substrate selectivity from kinetics nearly matched that of the Asn-to-Gln variant. The cumulative data from model glyco-enzyme MoLOX showcase how the presence, alteration, or removal of even a single N-linked glycan can influence the structural integrity and dynamics of the protein that are linked to an enzyme's catalytic proficiency, while indicating that extensive glycosylation protects the enzyme during pathogenesis by protecting it from protease degradation.


Sujet(s)
Lipoxygenase , Glycosylation , Lipoxygenase/métabolisme , Lipoxygenase/composition chimique , Lipoxygenase/génétique , Spécificité du substrat , Conformation des protéines , Domaine catalytique , Maturation post-traductionnelle des protéines , Protéines fongiques/métabolisme , Protéines fongiques/composition chimique , Protéines fongiques/génétique , Modèles moléculaires , Polyosides/métabolisme , Polyosides/composition chimique , Cinétique , Activation enzymatique
20.
Sci Total Environ ; 933: 173100, 2024 Jul 10.
Article de Anglais | MEDLINE | ID: mdl-38735330

RÉSUMÉ

Microplastics (MPs) are emerging pollutants of terrestrial ecosystems. The impacts of MP particle size on terrestrial systems remain unclear. The current study aimed to investigate the effects of six particle sizes (i.e., 4500, 1500, 500, 50, 5, and 0.5 µm) of polyethylene (PE) and polyvinyl chloride (PVC) on soil respiration, enzyme activity, bacteria, fungi, protists, and seed germination. MPs significantly promoted soil respiration, and the stimulating effects of PE were the strongest for medium and small-sized (0.5-1500 µm) particles, while those of PVC were the strongest for small particle sizes (0.5-50 µm). Large-sized (4500 µm) PE and all sizes of PVC significantly improved soil urease activity, while medium-sized (1500 µm) PVC significantly improved soil invertase activity. MPs altered the soil microbial community diversity, and the effects were especially pronounced for medium and small-sized (0.5-1500 µm) particles of PE and PVC on bacteria and fungi and small-sized (0.5 µm) particles of PE on protists. The impacts of MPs on bacteria and fungi were greater than on protists. The seed germination rate of Brassica chinensis decreased gradually with the decrease in PE MPs particle size. Therefore, to reduce the impact of MPs on soil ecosystems, effective measures should be taken to avoid the transformation of MPs into smaller particles in soil environmental management.


Sujet(s)
Germination , Microbiote , Microplastiques , Taille de particule , Microbiologie du sol , Polluants du sol , Microplastiques/pharmacologie , Polluants du sol/pharmacologie , Germination/effets des médicaments et des substances chimiques , Sol/composition chimique , Sol/parasitologie , Bactéries/effets des médicaments et des substances chimiques , Bactéries/enzymologie , Champignons/effets des médicaments et des substances chimiques , Champignons/enzymologie , Eucaryotes/effets des médicaments et des substances chimiques , Eucaryotes/enzymologie , Activation enzymatique/effets des médicaments et des substances chimiques , Microbiote/effets des médicaments et des substances chimiques , Biodiversité , Brassica/effets des médicaments et des substances chimiques , Brassica/croissance et développement
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...